Carol Marlene Investments Pty Limited is a limited by shares, Australian proprietary company. This corporation was registered on 1997-05-14 and was issued with the 078534568 ACN. Its Australian Business Number is 83078534568. Since 2020-11-03, the company is headquartered in NSW, post code 2011. The previous headquarters were located in NSW 2060 (from 2018-10-26 to 2020-11-03), NSW 2060 (from 2014-09-19 to 2018-10-26), and NSW 2060 (from 2013-05-02 to 2014-09-19). Carol Marlene Investments Pty Limited has been using the Carol Mallene Investments Pty Ltd trading name since 2000-07-18 (it needs to be noted that the Australian Business Register no longer collects or updates trading names). In total the company used 1 trading name. The above data comes from the ABN database which was updated on 2020-11-03.
| Status | From | To |
|---|---|---|
| Active | June 1, 2000 | current |
| Name | From | To |
|---|---|---|
| Carol Marlene Investments Pty. Limited | October 5, 2000 | current |
| Carol Marlene Investments P/l | June 1, 2000 | October 5, 2000 |
| Name | From | To |
|---|---|---|
| Carol Mallene Investments Pty Ltd | July 18, 2000 | current |
| Location | From | To |
|---|---|---|
| NSW 2011 | November 3, 2020 | current |
| NSW 2060 | October 26, 2018 | November 3, 2020 |
| NSW 2060 | September 19, 2014 | October 26, 2018 |
| NSW 2060 | May 2, 2013 | September 19, 2014 |
| NSW 2067 | July 18, 2000 | May 2, 2013 |
Advertisements
Contains public sector information licensed under the Creative Commons Attribution 3.0 Australia licence. Material on this website was obtained from publicly-accessible databases and is attributed to ©Commonwealth of Australia 2024 (http://data.gov.au, http://acnc.gov.au/ and http://abr.business.gov.au/), ©Intellectual Property Government Open Data 2024, ©ASIC - Company Register. While we try to make the information as precise and up-to-date as possible, we are aware the datasets are not always error-free. Aubiz.net will not take responsibility for any errors in the databases. The material provided should be treated as a starting point of more in-depth research, not as fact.